The Premier Meeting in the Field of Psychopharmacology
The meeting brings together over 1,000 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator awardees. ASCP is joined by federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA) to organize a program that emphasizes the presentation of information that has not been previously published or presented.
2027 Annual Meeting Sponsorships will be made available in the fall of 2026. If you have any questions or are interested in sponsoring, please contact the ASCP Executive Office at info@ascpp.org.
1,138 total attendees in 2026
The 2026 ASCP Annual Meeting welcomed 1,138 academicians, researchers, clinicians, and industry professionals from around the world who specialize in psychopharmacology.
Academicians
Researchers
Industry
Clinicians
Thank you, 2026 Sponsors!
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Global Representation
Countries Represented
States Represented
Attendee Satisfaction
%
Thought the program was current and relevant to professional practice or research.
%
Felt the 2026 Annual Meeting boosted their confidence in patient consultation and/or research they are conducting.
%
Believe the range of scientific topics offered at the 2026 Annual Meeting is better than most of the other meetings they attend.
%
Said the conference staff provided quality service.